Contineum Therapeutics, Inc. Shares Outstanding (Cover Page)
Contineum Therapeutics, Inc. (CTNM) had Shares Outstanding (Cover Page) of 23.10 million shares as of 2025-10-27, per its 10-Q filed 2025-10-30.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2025-10-30
- 2025-10-27: Entity Common Stock, Shares Outstanding 23.10M shares.
- 2025-07-31: Entity Common Stock, Shares Outstanding 28.04M shares.
- 2025-05-09: Entity Common Stock, Shares Outstanding 25.87M shares.
- 2025-02-28: Entity Common Stock, Shares Outstanding 25.87M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2025-10-27 | 23.10M shares 10-Q · filed 2025-10-30 |
| 2025-07-31 | 28.04M shares 10-Q · filed 2025-08-05 |
| 2025-05-09 | 25.87M shares 10-Q · filed 2025-05-14 |
| 2025-02-28 | 25.87M shares 10-K · filed 2025-03-06 |
| 2024-08-13 | 18.99M shares 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |